Latest updates for Cprsx
Fresh curated links around CPRSX are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
- Victory RS Partners Fund Q3 2026 Commentary
- XPH: Healthcare Sector Dashboard For October
- Clarion Partners Real Estate Income Fund Q2 2026 Commentary
Post angles to try
Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Fresh articles and ideas
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
seekingalpha.com
/3 weeks ago
Clarion Partners Real Estate Income Fund Q2 2026 Commentary
fool.com
/1 month ago
IXJ vs XPH: Global Healthcare ETF or Pharma Focus?
XPH delivered 57% returns over one year but swung 31% lower at its worst. IXJ offers steadier performance with higher income and $4.2 billion in assets for easier trading.
seekingalpha.com
/1 month ago
Royalty Pharma plc (RPRX) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
seekingalpha.com
/1 month ago
Royalty Pharma: The Quiet Compounder The Market Is Still Mispricing
seekingalpha.com
/3 days ago
Compass Pathways: Built The FDA's Way, Valued At 0.57x Spravato's Sales
psychedelicalpha.com
/1 month ago
Pα+ Psychedelic Bulletin #231: Compass Shares 52 Week Follow-Up, Training Grant Recipients; Xylo Enters the Clinic; RFK...
Compass Shares 52-Week Follow-Up and Five Training Grant Recipients Earlier this month, Compass Pathways shared topline data from Part C of its smaller, placebo-controlled Phase 3...
pharmexec.com
/2 weeks ago
<![CDATA[Roundup: TRexBio & Retension Pharmaceuticals Announce IPO Pricing ]]>
seekingalpha.com
/1 month ago
Vicore Pharma Holding AB (publ) (VCRE) Presents at European Respiratory Society (ERS) Congress - Slideshow
fool.com
/1 month ago
Better Healthcare ETF: Vanguard's VHT vs. State Street's Pharmaceuticals-Focused XPH
Vanguard's broader healthcare portfolio charges less and yields more, but State Street's pharma-focused fund has delivered stronger recent gains despite higher volatility.
biopharmadive.com
/2 weeks ago
FDA review docs spark Revolution sell-off; Zealand diabetes data underwhelm analysts
The new disclosure suggested Rasonque might not be as broadly effective as previously thought. Elsewhere, Ultragenyx got a much-needed cash infusion and TCGX started a China-focuse...
seekingalpha.com
/1 month ago
SPXX: Buy The Discount, Collect The Premium, Encash The Consolidation
prweb.com
/1 month ago
APS Introduces Health Wallets to Simplify Employee Spending Accounts and Reimbursements Benefits
Health Wallets provides employees with a dedicated app and single payment card, while streamlining administration for employers within APS OnLine. SHREVEPORT, La., Sept. 15, 2026 /...
Turn fresh research into a full content calendar
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.
Sources covering Cprsx
seekingalpha.com
Recent coverage from public sources
Public source
psilocybinalpha.com
Recent coverage from public sources
Public source
seekingalpha.com
Recent coverage from public sources
Public source
seekingalpha.com
Recent coverage from public sources
Public source
biopharmadive.com
Recent coverage from public sources
Public source
fool.com
Recent coverage from public sources
Public source